Article | 2021/06/22
These essential actions weave digital capabilities into each phase of the launch journey.
Article | 2021/06/09
Payers are reluctant to cover quality-of-life therapies without evidence that they also lower costs. Companies can convince them by taking this five-step approach.
Article | 2021/05/05
Biopharma companies should approach the coming year with a clear view of shifting expectations and market conditions.
Article | 2021/03/17
Field teams can take five actions to overcome resistance to change.
Article | 2021/03/04
The soaring demand for COVID-19 vaccines provides an opportunity for contract development and manufacturing organizations to deepen their relationships with biopharmaceutical customers and drive growth.
Article | 2021/02/17
Once a visionary ambition, synthetic control arms are poised to take off. Now is the time for pharma companies to identify opportunities and gain experience.
Article | 2021/01/25
A big part of improving immunotherapy for patients may lie in digital technology and analytics.
Article | 2021/01/19
Teams often struggle to execute external licensing agreements and M&A transactions that can supplement internal innovation and revenue. Six factors can enhance performance.
Indian Pharmaceutical Industry has been a global powerhouse for supply of affordable medicines. The publication explores Future of Work Thinking Around 5 Core Operating Pillars for Manufacturing.
Article | 2020/11/12
Multinational companies need to map a strategy to tap into China’s growth—and compete with increasingly innovative “homegrown” Chinese biopharma companies.